Thermo Fisher Scientific
TMO
1,749 hedge funds and large institutions have $128B invested in Thermo Fisher Scientific in 2020 Q2 according to their latest regulatory filings, with 179 funds opening new positions, 617 increasing their positions, 707 reducing their positions, and 90 closing their positions.
99% more first-time investments, than exits
New positions opened: 179 | Existing positions closed: 90
28% more capital invested
Capital invested by funds: $99.8B → $128B (+$28.2B)
4% more funds holding
Funds holding: 1,675 → 1,749 (+74)
3% more funds holding in top 10
Funds holding in top 10: 159 → 163 (+4)
1.13% more ownership
Funds ownership: 88.35% → 89.48% (+1.1%)
4% more call options, than puts
Call options by funds: $522M | Put options by funds: $503M
13% less repeat investments, than reductions
Existing positions increased: 617 | Existing positions reduced: 707
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$647M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
+$581M |
| 3 |
Nordea Investment Management
Stockholm,
Sweden
|
+$249M |
| 4 |
HL
Harding Loevner
Bridgewater,
New Jersey
|
+$200M |
| 5 |
Fisher Asset Management
Camas,
Washington
|
+$196M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$629M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$442M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$198M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$118M |
| 5 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
-$114M |
TMO Hedge Fund Activity: Q2 2020 in Review
1,749 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q2 2020, worth a combined $128B — up 28% from $99.8B a quarter earlier.
Buyers outnumbered sellers: 179 funds opened new TMO positions and 90 closed out — a net gain of 89 holders — while 617 added to existing stakes and 707 trimmed.
The largest buyer was BlackRock, adding an estimated $647M. The largest seller was T. Rowe Price Associates, cutting an estimated $629M.
- 1,749 institutional investors held Thermo Fisher Scientific (TMO) as of Q2 2020, up from 1,675 in Q1 2020.
- Funds reported $128B of Thermo Fisher Scientific stock for Q2 2020, up 28% quarter-over-quarter.
- 179 funds opened new Thermo Fisher Scientific positions in Q2 2020 and 90 closed out, a net change of +89 holders.
- The largest Thermo Fisher Scientific buyer in Q2 2020 was BlackRock, an estimated $647M added.
- The largest Thermo Fisher Scientific seller in Q2 2020 was T. Rowe Price Associates, an estimated $629M sold.
Based on aggregated 13F filings for Q2 2020.